» Articles » PMID: 30473952

Negative Pressure Wound Therapy with Instillation and Dwell Time in the Surgical Management of Severe Hidradenitis Suppurativa

Overview
Journal Cureus
Date 2018 Nov 27
PMID 30473952
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hidradenitis suppurativa (HS) is a physically debilitating disease that greatly impairs the quality of life of affected individuals. Advanced disease is often difficult to treat with topical and systemic therapies. Surgical resection of diseased skin has become paramount in HS management but proposes challenges of wound care and closure.

Methods: Four patients with a total of 12 complex wounds were treated over a three year period. All of the patients were males between the ages of 28 and 61 years. The lesions were located on the buttocks (n=5), chest (n=1), perianal (n=2), perineal (n=2), and axillary regions (n=2). A protocol of wide local excision, followed by negative pressure wound therapy with instillation and dwell time (NPWTi-d) to decrease bioburden and promote angiogenesis of the exposed base, and subsequent skin grafting was used. Patients remained hospitalized between procedures.

Results: The original wound area ranged from 210-540 cm. Skin grafts of comparable sizes were taken from donor sites. The average duration of NPWTi-d placement was 3.5 days and the average time from excision to wound coverage was 4.3 days. The percent of graft uptake ranged from 70%-90%. All patients were resolved of their local disease with no complications.

Conclusions: Surgical management of HS can be complicated by difficult closures. This case series demonstrates that wide local excision followed by NPWTi-d and skin grafting is able to achieve local resolution of disease in HS patients who have failed multiple minimally invasive therapies.

Citing Articles

A review of surgical and reconstructive techniques for hidradenitis suppurativa.

Wong H, Jiang J, Huang S, Zhu P, Ji X, Wang D Arch Dermatol Res. 2024; 316(6):270.

PMID: 38796609 DOI: 10.1007/s00403-024-03000-5.


Negative Pressure Wound Therapy with Instillation and Dwell Time Using Antiseptic Solution in Chronic Limb-threatening Ischemia.

Terabe Y, Kaneko N, Ando H Plast Reconstr Surg Glob Open. 2024; 12(2):e5578.

PMID: 38317653 PMC: 10843361. DOI: 10.1097/GOX.0000000000005578.


The Value of Negative-Pressure Wound Therapy and Flap Surgery in Hidradenitis Suppurativa - A Single Center Analysis of Different Treatment Options.

Stumpfe M, Horch R, Arkudas A, Cai A, Muller-Seubert W, Hauck T Front Surg. 2022; 9:867487.

PMID: 35836613 PMC: 9273893. DOI: 10.3389/fsurg.2022.867487.


The role of negative-pressure wound therapy in the management of axillary hidradenitis suppurativa.

Ezanno A, Fougerousse A, Guillem P Int Wound J. 2021; 19(4):802-810.

PMID: 34590422 PMC: 9013599. DOI: 10.1111/iwj.13678.


Office-Based Surgical Intervention for Hidradenitis Suppurativa (HS): A Focused Review for Dermatologists.

Saylor D, Brownstone N, Naik H Dermatol Ther (Heidelb). 2020; 10(4):529-549.

PMID: 32435998 PMC: 7367977. DOI: 10.1007/s13555-020-00391-x.


References
1.
Kuo H, Ohara K . Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique. Dermatol Surg. 2003; 29(2):173-8. DOI: 10.1046/j.1524-4725.2003.29044.x. View

2.
Join-Lambert O, Coignard-Biehler H, Jais J, Delage M, Guet-Revillet H, Poiree S . Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. J Antimicrob Chemother. 2015; 71(2):513-20. DOI: 10.1093/jac/dkv361. View

3.
Sotiriou E, Apalla Z, Vakirlis E, Ioannides D . Efficacy of adalimumab in recalcitrant hidradenitis suppurativa. Eur J Dermatol. 2009; 19(2):180-1. DOI: 10.1684/ejd.2008.0599. View

4.
Davis K, Bills J, Barker J, Kim P, Lavery L . Simultaneous irrigation and negative pressure wound therapy enhances wound healing and reduces wound bioburden in a porcine model. Wound Repair Regen. 2013; 21(6):869-75. DOI: 10.1111/wrr.12104. View

5.
Kurtz S, Lau E, Watson H, Schmier J, Parvizi J . Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012; 27(8 Suppl):61-5.e1. DOI: 10.1016/j.arth.2012.02.022. View